Monica Alvarez-Villa

Oviedo, AS 33006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

NK Cells in the Treatment of Hematological Malignancies.

NK Cells in the Treatment of Hematological Malignancies.

Journal: Journal of clinical medicine

Published: August 09, 2019

The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.

The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.

Journal: Frontiers in immunology

Published: April 24, 2019

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia.

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia.

Journal: Frontiers in immunology

Published: May 14, 2018

Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia.

Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia.

Journal: Oncoimmunology

Published: January 30, 2017

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042).

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042).

Journal: PloS one

Published: February 12, 2015

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.

Journal: PloS one

Published: June 03, 2014

Molecular Bases for the Regulation of NKG2D Ligands in Cancer.

Molecular Bases for the Regulation of NKG2D Ligands in Cancer.

Journal: Frontiers in immunology

Published: December 20, 2013

NKG2D signaling in cancer immunosurveillance.

NKG2D signaling in cancer immunosurveillance.

Journal: International journal of cancer

Published: September 09, 2013

Lenalidomide and chronic lymphocytic leukemia.

Lenalidomide and chronic lymphocytic leukemia.

Journal: BioMed research international

Published: May 28, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026